Northwest Biotherapeutics

Developer of dendritic cell-based vaccines for prostate and brain cancer

placeBethesda, Maryland, United States calendar_todayFounded 1998 groups22 employees language nwbio.com

Registered entities

Innovation

24 patent families (18 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Operations & transport; filing pace slowing. Cited 1,938 times.

YearFilings
20158
20169
201710
20185
20195
20204
20218
20225
20234
20245
20253
20262

Investor mix

3 investors on record.

Investor typeCountShare
Other / undisclosed3100%
Coming soon